Abstract
Variation in the blood metabolome is intimately related to human health. However, few details are known about the interplay between genetics and the microbiome in explaining this variation on a metabolite-by-metabolite level. Here, we perform analyses of variance for each of 930 blood metabolites robustly detected across a cohort of 1,569 individuals with paired genomic and microbiome data while controlling for a number of relevant covariates. We find that 595 (64%) of these blood metabolites are significantly associated with either host genetics or the gut microbiome, with 69% of these associations driven solely by the microbiome, 15% driven solely by genetics and 16% under hybrid genome–microbiome control. Additionally, interaction effects, where a metabolite–microbe association is specific to a particular genetic background, are quite common, albeit with modest effect sizes. This knowledge will help to guide targeted interventions designed to alter the composition of the human blood metabolome.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Data availability
Qualified researchers can access the full Arivale deidentified dataset supporting the findings in this study for research purposes through signing of a data use agreement. Enquiries to access the data can be made at data-access@isbscience.org and will be responded to within seven business days. The raw 16S amplicon sequencing data can be found in the Sequencing Read Archive under Bioproject nos. PRJNA826530 and PRJNA826648. External databases used were the hg19 human reference genome (https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.13), SILVA database v.128 (https://www.arb-silva.de/) and NCBI dbSNP database build 155 (https://www.ncbi.nlm.nih.gov/snp/).
Code availability
Pipelines for 16S amplicon data processing and analysis can be found at https://github.com/Gibbons-Lab/mbtools. GWAS workflows, Jupyter notebooks, intermediate data files and Python code for reproducing the regression models and figures have been deposited at https://github.com/Gibbons-Lab/2021_gene_environment_interactions.
References
Bar, N. et al. A reference map of potential determinants for the human serum metabolome. Nature 588, 135–140 (2020).
Wang, X. & Paigen, B. Genetics of variation in HDL cholesterol in humans and mice. Circ. Res. 96, 27–42 (2005).
Blau, N., van Spronsen, F. J. & Levy, H. L. Phenylketonuria. Lancet 376, 1417–1427 (2010).
Gieger, C. et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 4, e1000282 (2008).
Yu, B. et al. Genetic determinants influencing human serum metabolome among African Americans. PLoS Genet. 10, e1004212 (2014).
Gallois, A. et al. A comprehensive study of metabolite genetics reveals strong pleiotropy and heterogeneity across time and context. Nat. Commun. 10, 4788 (2019).
Wilmanski, T. et al. Blood metabolome predicts gut microbiome α-diversity in humans. Nat. Biotechnol. 37, 1217–1228 (2019).
Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).
Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789–799 (2014).
Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).
Jiao, Y., Lu, Y. & Li, X.-Y. Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis. Acta Pharmacol. Sin. 36, 44–50 (2015).
Zheng, X. et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 33, 791–803 (2021).
Lees, H. J., Swann, J. R., Wilson, I. D., Nicholson, J. K. & Holmes, E. Hippurate: the natural history of a mammalian-microbial cometabolite. J. Proteome Res. 12, 1527–1546 (2013).
Nakamura, A. et al. Symbiotic polyamine metabolism regulates epithelial proliferation and macrophage differentiation in the colon. Nat. Commun. 12, 2105 (2021).
Vitali, C., Khetarpal, S. A. & Rader, D. J. HDL cholesterol metabolism and the risk of CHD: new insights from human genetics. Curr. Cardiol. Rep. 19, 132 (2017).
Kenny, D. J. et al. Cholesterol metabolism by uncultured human gut bacteria influences host cholesterol level. Cell Host Microbe 28, 245–257 (2020).
Dayama, G., Priya, S., Niccum, D. E., Khoruts, A. & Blekhman, R. Interactions between the gut microbiome and host gene regulation in cystic fibrosis. Genome Med. 12, 12 (2020).
Hunter, D. J. Gene-environment interactions in human diseases. Nat. Rev. Genet. 6, 287–298 (2005).
Liu, G. et al. Analyzing large-scale samples confirms the association between the ABCA7 rs3764650 polymorphism and Alzheimer’s disease susceptibility. Mol. Neurobiol. 50, 757–764 (2014).
Cuyvers, E. et al. Mutations in ABCA7 in a Belgian cohort of Alzheimer’s disease patients: a targeted resequencing study. Lancet Neurol. 14, 814–822 (2015).
Huynh, K. et al. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease. Nat. Commun. 11, 5698 (2020).
Bosma, P. J. et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J. Biol. Chem. 269, 17960–17964 (1994).
Wikoff, W. R. et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA 106, 3698–3703 (2009).
Teufel, R. et al. Bacterial phenylalanine and phenylacetate catabolic pathway revealed. Proc. Natl Acad. Sci. USA 107, 14390–14395 (2010).
Pallister, T. et al. Hippurate as a metabolomic marker of gut microbiome diversity: modulation by diet and relationship to metabolic syndrome. Sci. Rep. 7, 13670 (2017).
Brial, F. et al. Human and preclinical studies of the host-gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health. Gut 70, 2105–2114 (2021).
Ridlon, J. M., Kang, D. J., Hylemon, P. B. & Bajaj, J. S. Bile acids and the gut microbiome. Curr. Opin. Gastroenterol. 30, 332–338 (2014).
Winham, S. J. & Biernacka, J. M. Gene-environment interactions in genome-wide association studies: current approaches and new directions. J. Child Psychol. Psychiatry 54, 1120–1134 (2013).
Jain, M. et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336, 1040–1044 (2012).
Maceyka, M. & Spiegel, S. Sphingolipid metabolites in inflammatory disease. Nature 510, 58–67 (2014).
Matsumura, T. et al. N-acetyl-l-tyrosine is an intrinsic triggering factor of mitohormesis in stressed animals. EMBO Rep. 21, e49211 (2020).
de Aguiar Vallim, T. Q., Tarling, E. J. & Edwards, P. A. Pleiotropic roles of bile acids in metabolism. Cell Metab. 17, 657–669 (2013).
King, C. D., Rios, G. R., Green, M. D. & Tephly, T. R. UDP-glucuronosyltransferases. Curr. Drug Metab. 1, 143–161 (2000).
Alnouti, Y. Bile acid sulfation: a pathway of bile acid elimination and detoxification. Toxicol. Sci. 108, 225–246 (2009).
Xiang, X. et al. Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans. Pharmacogenet. Genomics 19, 447–457 (2009).
Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).
Tóth, B. et al. Human OATP1B1 (SLCO1B1) transports sulfated bile acids and bile salts with particular efficiency. Toxicol. In Vitro 52, 189–194 (2018).
Meikle, P. J. & Summers, S. A. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. Nat. Rev. Endocrinol. 13, 79–91 (2017).
Chaurasia, B. et al. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science 365, 386–392 (2019).
Mielke, M. M. et al. Serum ceramides increase the risk of Alzheimer disease: the Women’s Health and Aging Study II. Neurology 79, 633–641 (2012).
Green, D. R. Apoptosis and sphingomyelin hydrolysis. The flip side. J. Cell Biol. 150, F5–F7 (2000).
Summers, S. A., Chaurasia, B. & Holland, W. L. Metabolic messengers: ceramides. Nat. Metab. 1, 1051–1058 (2019).
Johnson, E. L. et al. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. Nat. Commun. 11, 2471 (2020).
Ervin, R. B., Wright, J. D., Wang, C.-Y. & Kennedy-Stephenson, J. Dietary intake of fats and fatty acids for the United States population: 1999-2000. Adv. Data 348, 1–6 (2004).
Fan, Y., Meng, H.-M., Hu, G.-R. & Li, F.-L. Biosynthesis of nervonic acid and perspectives for its production by microalgae and other microorganisms. Appl. Microbiol. Biotechnol. 102, 3027–3035 (2018).
Liu, X. et al. Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nat. Genet. 54, 52–61 (2022).
Maddocks, O. D. K. et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature 544, 372–376 (2017).
Tevzadze, G. et al. Effects of a gut microbiome toxin, p-cresol, on the indices of social behavior in rats. Neurophysiology 50, 372–377 (2018).
Oelberg, D. G., Little, J. M., Adcock, E. W. & Lester, R. Intestinal absorption of bile acid glucuronides in rats. Dig. Dis. Sci. 33, 1110–1115 (1988).
Creekmore, B. C. et al. Mouse gut microbiome-encoded β-glucuronidases identified using metagenome analysis guided by protein structure. mSystems 4, e00452–19 (2019).
Gloux, K. et al. A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome. Proc. Natl Acad. Sci. USA 108, 4539–4546 (2011).
Begley, M., Gahan, C. G. M. & Hill, C. The interaction between bacteria and bile. FEMS Microbiol. Rev. 29, 625–651 (2005).
Stankeviciute, G. et al. Convergent evolution of bacterial ceramide synthesis. Nat. Chem. Biol. 18, 305–312 (2021).
Dinoff, A., Herrmann, N. & Lanctôt, K. L. Ceramides and depression: a systematic review. J. Affect. Disord. 213, 35–43 (2017).
Dekkers, K. F. et al. An online atlas of human plasma metabolite signatures of gut microbiome composition. Nat. Commun. 13, 5370 (2022).
Zubair, N. et al. Genetic predisposition impacts clinical changes in a lifestyle coaching program. Sci. Rep. 9, 6805 (2019).
Jiang, L. et al. A resource-efficient tool for mixed model association analysis of large-scale data. Nat. Genet. 51, 1749–1755 (2019).
Xu, C. et al. Estimating genome-wide significance for whole-genome sequencing studies. Genet. Epidemiol. 38, 281–290 (2014).
Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
Conomos, M. P., Reiner, A. P., Weir, B. S. & Thornton, T. A. Model-free estimation of recent genetic relatedness. Am. J. Hum. Genet. 98, 127–148 (2016).
Acknowledgements
S.M.G. and C.D. were supported by the Washington Research Foundation Distinguished Investigator Award and start-up funds from the Institute for Systems Biology. Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) under award no. R01DK133468 (to S.M.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in designing, carrying out or interpreting the work presented in the manuscript. T.W. was supported by a generous gift from C. Ellison. Further support came from the NIH (grant no. U19AG023122) awarded by the National Institute on Aging (to N.R.).
Author information
Authors and Affiliations
Contributions
Conceptualization was carried out by C.L.D., C.D., S.M.G. and A.T.M. Methodology was the responsibility of C.D. and C.L.D. C.D., C.L.D., T.W., N.R. and B.S. performed formal analysis. C.D., C.L.D., B.S., S.M.G. and A.T.M. carried out investigations. Data curation was undertaken by C.L.D., B.S. and A.T.M. C.D., C.L.D. and S.M.G. wrote the original draft. Writing, review and editing were carried out by C.D., C.L.D., T.W., P.B., S.M.G. and A.T.M. Visualization was undertaken by C.D. and C.L.D. Supervision and project administration were performed by L.H., A.T.M. and S.M.G.
Corresponding authors
Ethics declarations
Competing interests
C.L.D., B.S. and A.T.M. are former employees of, and held stock options in, Arivale, Inc. L.H. is a former shareholder of Arivale. Arivale is no longer a commercially operating company as of April 2019. The remaining authors report no competing interests.
Peer review
Peer review information
Nature Metabolism thanks Aleksandar D. Kostic and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Genome-wide association study results.
Genome-wide association p-values for variants associated with at least one metabolite (only p < 1e-5 shown here). Red dashed line denotes genome-wide significance (p < 5.37e-11). Gray bars denote separation between chromosomes. N = 1,000 (training cohort). The full list of p-values from the GWAS analysis can be found in Supplementary Table S4.
Extended Data Fig. 2 Gene-microbiome interactions explain variation in blood metabolite levels (unadjusted data).
Shown are six selected examples where the genomic background modulates the associations between bacterial genus-level abundances and metabolite levels. In (A-F) metabolite abundances were log-transformed, but no adjustment for common confounders, was performed here. In (A-F) “ρ” denotes the Spearman’s Rank-Order correlation coefficient of the regression and “p” denotes the p-value under a two-sided Spearman’s correlation test. The solid line indicates an ordinary least squares regression line relating the transformed metabolite abundance with the transformed genus abundance within each group. The shaded area is the 95% confidence interval of the regression. Associations were corrected for sex, age, age², sex:age, and sex:age² interactions, BMI, microbiome vendor, metabolomics batch, and the first 5 principal components of genetic ancestry (N = 1,569). Metabolite names ending in “*” or “**” indicate compounds for which a standard is not available, but Metabolon is confident in its identity.
Supplementary information
Supplementary Table 1.
Supplementary Tables 1–5.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Diener, C., Dai, C.L., Wilmanski, T. et al. Genome–microbiome interplay provides insight into the determinants of the human blood metabolome. Nat Metab 4, 1560–1572 (2022). https://doi.org/10.1038/s42255-022-00670-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-022-00670-1
This article is cited by
-
Variant of the lactase LCT gene explains association between milk intake and incident type 2 diabetes
Nature Metabolism (2024)
-
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Signal Transduction and Targeted Therapy (2024)
-
Comparison of fecal and blood metabolome reveals inconsistent associations of the gut microbiota with cardiometabolic diseases
Nature Communications (2023)